SCHEMBL4763384

SCHEMBL4763384

COCCn1c(/C=C/c2cnn(Cc3ccccc3C(F)(F)F)c2)c([N+](=O)[O-])c(=O)n(CCOC)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 4/20 0.44
ADORA1 P30542 4/20 0.44
ADORA2A P29274 3/20 0.44
ALDH1A1 P00352 3/20 0.35
MAPK1 P28482 2/20 0.35
MAPT P10636 2/20 0.35
NPBWR1 P48145 1/20 0.35
PKM P14618 1/20 0.34
SCD5 Q86SK9 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
TAS2R8 Q9NYW2 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
MITF O75030 1/20 0.33
KLKB1 P03952 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4766139 0.97 ADORA2B (0.49) ADORA2BADORA1ADORA2AMAPTPOLB
SCHEMBL4769319 0.95 ADORA2B (0.44) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4766145 0.92 ADORA2B (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4771427 0.90 ADORA2B (0.41) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4770754 0.89 ADORA2B (0.48) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4770747 0.89 ADORA2B (0.48) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4769690 0.88 ADORA2B (0.52) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4769673 0.88 ADORA2B (0.52) ADORA2BADORA1ADORA2AADORA3
SCHEMBL4763165 0.88 ADORA2B (0.43) ADORA2BADORA1ADORA2AALDH1A1MAPK1
SCHEMBL4763171 0.88 ADORA2B (0.43) ADORA2BADORA1ADORA2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed